Research News

Targeting Tumor Metabolism to Fight Cancer

By Chris Woolston, WashU | June 10, 2026

Cancer cells are ravenous eaters. Gary Patti is trying to turn their hunger against them. By their nature, cancer cells have different nutritional needs than healthy cells. “Cancer cells have a distinct metabolism,” said Gary…

Siteman Cancer Center Shares the Latest in Medical Oncology, Screening Innovation and Translational Science at ASCO

By Siteman Communications | May 27, 2026

WashU Medicine physician-scientists and others affiliated with Siteman will share findings from multi-institutional studies they lead and will present on health equity, mentorship and more at the 2026 American Society of Clinical Oncology (ASCO) Annual…

A new study led by WashU Medicine researchers shows that, for blood cancer patients, a genetically engineered stem cell transplant helps prevent toxic side effects and potentially improves the effectiveness of therapies.

News/In the Media, Research

Gene-Edited Stem Cell Transplant Shows Promise for Aggressive Blood Cancers

By Julia Evangelou Strait, WashU Medicine | May 12, 2026

Strategy seeks to expand immunotherapies for leukemia, other malignancies For highly aggressive types of blood cancer, stem cell transplantation is often the only potentially curative therapy, yet even after a transplant, these cancers often return….

Patient Kim Garland (left) reviews a scan with Tanner Johanns, MD, PhD.

News/In the Media, Research

Personalized Vaccine Shows Promise Against Aggressive Brain Cancer

By Mark Reynolds, WashU Medicine | May 12, 2026

Participants in early clinical trial had increased immune response, slowed tumor progression A personalized vaccine to treat glioblastoma, a fast-growing and incurable brain cancer that affects four in 100,000 people in the U.S., is safe…

Headshots of Jeremy Baeten, PhD, and Matthew Walter, MD

News/In the Media, Research, Staff/Faculty Update

Grants Bolster Research on Myelodysplastic Syndromes

By WashU Medicine | April 21, 2026

Foundation awards $1.5 million total in grants to WashU Medicine researchers at Siteman Cancer Center to advance precision diagnosis and treatment for patients with myelodysplastic syndromes The Edward P. Evans Foundation has awarded separate three-year…

News/In the Media, Research, Staff/Faculty Update

Siteman Catalyst Awards Support Groundbreaking Science

By Siteman Communications | April 17, 2026

Four researchers receive new funding to explore brain‑sparing radiation, smarter leukemia drugs, better BRCA1 risk prediction and new strategies against aggressive pancreatic cancer Four WashU Medicine researchers at Siteman Cancer Center, based at Barnes-Jewish Hospital…

Research lab manager Julie Ritchey manufactures cells in the current Good Manufacturing Practice (cGMP) lab at WashU Medicine and Siteman Cancer Center

News/In the Media, Research, Staff/Faculty Update

Siteman Cancer Center Experts to be Recognized, Present Key Research at AACR Annual Meeting

By Siteman Communications | April 16, 2026

Two WashU Medicine physician-scientists will be honored, and 30 faculty members and others will present findings at the American Association for Cancer Research (AACR) Annual Meeting 2026, taking place April 17-22 in San Diego. …

An illustration depicts two subsets of dendritic cells, both of which mRNA vaccination uses to stop cancer, according to new WashU Medicine research at Siteman Cancer Center.

News/In the Media, Research

mRNA Technology Opens Doors for Potential New Ways of Preventing and Treating Cancer

By Marta Wegorzewska, WashU Medicine | April 16, 2026

WashU Medicine researchers at Siteman Cancer Center are leading next-generation cancer vaccine development. The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel-prize–winning technology is being…

Immunotherapy for head and neck cancer. Shown is an artist's rendering of immune cells (light blue) attacking a cancer cell.

Clinical, News/In the Media, Research

Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery

By Stephanie Stemmler, Medical Writer | March 31, 2026

WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center,…

An image of the interior of Wugen, a startup that has licensed an innovative cell-based immunotherapy designed to treat rare and aggressive types of blood cancer. The therapy has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA)

Clinical, News/In the Media, Research

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation

By Julia Evangelou Strait, WashU Medicine | March 26, 2026

Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by…

1 2 3 … 25 Next

Siteman earns prestigious merit extension from National Cancer Institute

How Siteman is leading the way in personalized brain tumor treatment

Siteman to Welcome First Patients in New Building Dedicated Exclusively to Cancer Care

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman earns prestigious merit extension from National Cancer Institute

Siteman earns prestigious merit extension from National Cancer Institute

How Siteman is leading the way in personalized brain tumor treatment

Treatment
Clinical
How Siteman is leading the way in personalized brain tumor treatment
If you or a loved one have recently been diagnosed with a brain tumor, you likely feel a great deal of fear and have many questions. The brain is the epicenter of who we are,...
Read The Full Story

How Siteman is leading the way in personalized brain tumor treatment

Specialized Programs

Adult Cancer Types

Childhood Cancer Programs

The Siteman Approach

Siteman to Welcome First Patients in New Building Dedicated Exclusively to Cancer Care

Siteman to Welcome First Patients in New Building Dedicated Exclusively to Cancer Care

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Couple honors physician with gift for distinguished professorship

Research News

Targeting Tumor Metabolism to Fight Cancer

Siteman Cancer Center Shares the Latest in Medical Oncology, Screening Innovation and Translational Science at ASCO

Gene-Edited Stem Cell Transplant Shows Promise for Aggressive Blood Cancers

Personalized Vaccine Shows Promise Against Aggressive Brain Cancer

Grants Bolster Research on Myelodysplastic Syndromes

Siteman Catalyst Awards Support Groundbreaking Science

Siteman Cancer Center Experts to be Recognized, Present Key Research at AACR Annual Meeting

mRNA Technology Opens Doors for Potential New Ways of Preventing and Treating Cancer

Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation